Hepatitis C News

Prescriptions for direct-acting antivirals to treat hepatitis C virus in the U.S. have declined substantially since 2015 and remain well below the approximately 260,000 annual treatment courses needed to meet the target for elimination.

NIH Director Jay Bhattacharya, MD, PhD, was selected in February to also serve as acting director of the CDC, continuing the unprecedented turnover atop what is widely considered to be the world’s premier public health agency.

NIH Director Jay Bhattacharya, MD, PhD, has been picked to also serve as acting director of the CDC, a White House official confirmed to Healio. Bhattacharya will oversee both agencies until a permanent CDC director is nominated and confirmed, the official said.

More than a year into the second Trump administration, the CDC is still operating without a permanent director — which, former CDC officials said, puts national health and safety at risk.

On Thursday, HHS announced that the United States has completed its withdrawal from WHO.

The number of physicians who matched in fellowship programs for adult infectious diseases declined in 2025, according to Match Day stats released in December.

HHS has reversed its decision to cancel thousands of grants supporting mental health and substance use treatment and services, according to the National Council for Mental Wellbeing.

People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current standards call for.

The American Association for the Study of Liver Diseases and Infectious Diseases Society of America have updated guidance on treatment of chronic hepatitis B virus, which the authors hope will give clinicians and patients more flexibility.